Journal article · 2026 · Open access

ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY

2Ms. Neha Satish Shinde 1*Prof. Ashwini Shrikrushna Taware

World Journal of Pharmaceutical Research · Published 1 May 2026 · DOI 10.5281/zenodo.19875019

Read the free full textCite this paper

In brief

“ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY” is a 2026 journal article by 2Ms. Neha Satish Shinde 1*Prof. Ashwini Shrikrushna Taware, published in World Journal of Pharmaceutical Research. OpenAlex counts 0 citations as of 15 November 2026. It is open access under a CC BY licence: the full text is free to read at World Journal of Pharmaceutical Research.

Citations
0
Authors
1

Abstract

Artificial Intelligence (AI) has rapidly transformed the landscape of drug development by enabling data-driven, efficient, and predictive approaches across the pharmaceutical pipeline. This review provides a comprehensive overview of AI applications in drug development, highlighting its core functions, advantages over traditional systems, and real-world implementations. The fundamental functions of AI including pattern recognition, predictive modeling, data mining, and decision support facilitate the analysis of complex biological, chemical, and clinical datasets with high accuracy and speed. The review contrasts AI-based approaches with conventional drug development methods, which are often limited by high costs, prolonged timelines, low success rates, and reliance on trial-and-error experimentation. By addressing these drawbacks, AI enhances target identification, lead optimization, and safety profiling while reducing attrition rates. Common examples of AI technologies discussed include machine learning algorithms, deep learning models, natural language processing, and expert systems, all of which contribute to improved computational efficiency and knowledge extraction. Furthermore, the application of AI in drug development is explored in detail, including virtual screening, drug target interaction prediction, de novo drug design, pharmacokinetic and toxicity prediction (ADMET), clinical trial optimization, and drug repurposing. Despite its transformative potential, challenges such as data quality, interpretability, ethical concerns, and regulatory acceptance remain significant. This review concludes that AI represents a paradigm shift in drug development, offering substantial opportunities to enhance innovation, reduce costs, and accelerate the delivery of safe and effective therapeutics.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Taware, N. S. S. A. S. (2026). ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY. World Journal of Pharmaceutical Research. https://doi.org/10.5281/zenodo.19875019

MLA 9

Taware, 2Ms. Neha Satish Shinde 1*Prof. Ashwini Shrikrushna. “ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY.” World Journal of Pharmaceutical Research, 2026. https://doi.org/10.5281/zenodo.19875019.

Chicago

Taware, 2Ms. Neha Satish Shinde 1*Prof. Ashwini Shrikrushna. 2026. “ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY.” World Journal of Pharmaceutical Research. https://doi.org/10.5281/zenodo.19875019.

Harvard

Taware, N. S. S. A. S. (2026) ‘ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY’, World Journal of Pharmaceutical Research. doi:10.5281/zenodo.19875019.

IEEE

N. S. S. A. S. Taware, “ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY,” World Journal of Pharmaceutical Research, 2026, doi: 10.5281/zenodo.19875019.

BibTeX

@article{taware2026artificial,
  title     = {{ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY}},
  author    = {Taware, 2Ms. Neha Satish Shinde 1*Prof. Ashwini Shrikrushna},
  journal   = {World Journal of Pharmaceutical Research},
  year      = {2026},
  doi       = {10.5281/zenodo.19875019},
  url       = {https://doi.org/10.5281/zenodo.19875019}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods

  • artificial intelligence in drug discovery
  • drug development
  • machine learning
  • deep learning
  • natural language processing
  • expert systems
  • virtual screening
  • drug-target interaction prediction

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Taware, N. S. S. A. S. (2026). ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY. World Journal of Pharmaceutical Research. https://doi.org/10.5281/zenodo.19875019

How many times has this paper been cited?

0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at World Journal of Pharmaceutical Research.

Who wrote this paper?

2Ms. Neha Satish Shinde 1*Prof. Ashwini Shrikrushna Taware.

What is the DOI of this paper?

10.5281/zenodo.19875019. The permanent link is https://doi.org/10.5281/zenodo.19875019.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.